FRANKFURT, March 1 (Reuters) - Schwarz Pharma’s (SRZG.DE: Quote, Profile, Research) Neupro drug for the treatment of early Parkinson’s disease has won an approvable letter from the U.S. Food and Drug Administration (FDA), the German company said on Wednesday.
